INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 120 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $579,000 | -36.6% | 140,100 | -2.7% | 0.06% | -36.8% |
| Q3 2017 | $913,000 | -19.1% | 144,000 | 0.0% | 0.10% | -28.6% |
| Q2 2017 | $1,129,000 | +18.5% | 144,000 | 0.0% | 0.13% | +4.7% |
| Q1 2017 | $953,000 | -11.4% | 144,000 | -7.1% | 0.13% | -42.3% |
| Q4 2016 | $1,076,000 | -25.5% | 155,000 | 0.0% | 0.22% | -15.7% |
| Q3 2016 | $1,445,000 | +0.9% | 155,000 | 0.0% | 0.26% | -3.0% |
| Q2 2016 | $1,432,000 | -38.0% | 155,000 | -41.5% | 0.27% | -35.8% |
| Q1 2016 | $2,308,000 | – | 265,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |